LSE - Delayed Quote GBp

Beximco Pharmaceuticals Limited (BXP.L)

Compare
38.44
-0.06
(-0.16%)
As of 8:00:16 AM GMT. Market Open.
All numbers in thousands
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
69,344,022.64
69,156,783.25
66,148,035.74
52,246,084.03
Total Liabilities Net Minority Interest
17,441,119.76
21,537,117.27
21,512,031.28
14,881,219.20
Total Equity Gross Minority Interest
51,902,902.88
47,619,665.98
44,636,004.46
37,364,864.83
Total Capitalization
47,949,964.74
45,838,420.76
43,597,925.08
38,003,254.67
Common Stock Equity
47,949,964.74
43,680,703.74
40,600,497.82
37,030,558.20
Capital Lease Obligations
--
539,638.07
617,340.62
347,996.90
Net Tangible Assets
42,554,697.68
38,285,098.92
35,196,089.22
35,103,173.18
Working Capital
11,255,597.58
7,610,830.20
5,683,326.21
4,421,167.77
Invested Capital
50,946,624.71
53,752,964.36
52,353,858.84
44,313,865.54
Tangible Book Value
42,554,697.68
38,285,098.92
35,196,089.22
35,103,173.18
Total Debt
6,025,430.73
10,611,898.69
12,370,701.63
7,631,304.24
Net Debt
2,142,554.31
8,936,574.45
10,584,687.20
6,607,840.73
Share Issued
446,112.09
446,112.09
446,112.09
446,112.09
Ordinary Shares Number
446,112.09
446,112.09
446,112.09
446,112.09
6/30/2021 - 10/21/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade